BioSpace News Archive

Press Releases

GRI Bio Receives Authorization to Conduct Phase 2a Biomarker Study Evaluating GRI-0621 in Australia

September 27, 2024
·
7 min read
Press Releases

Ovid Therapeutics Presents Pre-Clinical Study Results Demonstrating OV329 Does Not Accumulate in Animal Eyes in Contrast with Vigabatrin

September 27, 2024
·
9 min read
Press Releases

Cardurion Pharmaceuticals Appoints Ron Renaud to Board of Directors

September 27, 2024
·
3 min read
Press Releases

ATCC Announces Award from NIAID to Support Preclinical Models of Infectious Diseases

September 27, 2024
·
3 min read
Press Releases

Alnylam to Webcast TTR Investor Day

September 27, 2024
·
2 min read
Press Releases

Kane Biotech Announces Attendance at Upcoming Wound Care Conferences

September 27, 2024
·
3 min read
Press Releases

Allogene Therapeutics to Present Pre-Clinical Data Highlighting the Potential of ALLO-329, an Allogeneic CD19/CD70 Dual CAR T for the Treatment of Autoimmune Diseases, at the American College of Rheumatology (ACR) Convergence

September 27, 2024
·
6 min read
Press Releases

Twelve-Month Results from Landmark QUEST Study Published in Neuromodulation

September 27, 2024
·
5 min read
Press Releases

Thermo Fisher Scientific Expands Oral Solid Dose Development and Manufacturing Capabilities Across North America

September 27, 2024
·
3 min read
Press Releases

Longboard Pharmaceuticals Initiates Phase 3 DEEp SEA Study Evaluating Bexicaserin in Dravet Syndrome

September 27, 2024
·
6 min read